New Clinical Research Site Survey Reveals the Prevalence and Significant Cost of Paper Source Documents
Contact:
Mary D’Rozario
Director of Communications
Society for Clinical Research Sites
919.890.5513
mary.drozario@myscrs.org
FOR IMMEDIATE RELEASE
New Clinical Research Site Survey Reveals the Prevalence and Significant Cost of Paper Source Documents
Ellicott City, MD, May 12, 2017 – The Society for Clinical Research Sites (SCRS) and Clinical Ink have released a white paper titled, “Why Is Clinical Source Data Still Collected on Paper?” Building on data from the Research Site Source Survey of 650 global research sites, it calculates the total cost of paper source documents and manual transcription.
With the widespread adoption of EMR and EDC solutions, it is easy to assume that the industry has streamlined the process of collecting study data. The surprising reality is 90% of sites are still collecting trial data on paper.
“We found that creating paper source documents is a significant site expense,” said Christine Pierre, president of SCRS. “Electronic medical record adoption and eSource regulation have brought the promise of eliminating this expense. In this paper, we explore the current landscape and potential savings and quality improvement of increased use of eSource.”
“Reducing the burden on clinical sites while improving protocol execution and data quality for sponsors has been our core focus since the company’s inception, said Doug Pierce, President Clinical Ink. As the pioneer in protocol driven eSource solutions, we recognized early on that EDC and EMR cannot deliver these improvements. The survey and white paper highlight the time and cost associated with the paper process today and a path forward.”
###
About Clinical Ink®
Founded in 2007, Clinical Ink® is transforming clinical development with innovative technologies that make clinical research easier for sites, sponsors and patients. Clinical Ink’s SureSource® comprehensive platform directly captures eSource data and documents and improves patient engagement by focusing on the critical moments that matter when executing the protocol. Clinical Ink maintains offices in Cambridge, MA, Winston-Salem, NC, and Philadelphia, PA. Find more at www.clinicalink.com.
About SCRS
SCRS is a global trade organization founded in 2012 which represents over 4,000 research sites in over 45 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites and the companies that sponsor or support the work conducted at clinical research sites will benefit from membership and partnership. Our Voice. Our Community. Your Success. Join the community and collaborate with the global experts in site sustainability. Visit MySCRS.org.
